Damora Therapeutics Inc (DMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 30,811 | 201,696 | 3,156 | 3,421 | 2,599 |
| Operating Income | -30,811 | -201,696 | -3,156 | -3,421 | -2,599 |
| Other Income | 3,070 | 1,004 | 23 | -12 | 68 |
| Pre-tax Income | -27,741 | -200,692 | -3,133 | -3,433 | -2,531 |
| Income Tax | 42 | 44 | N/A | 4 | 2 |
| Net Income Continuous | -27,783 | -200,736 | -3,133 | -3,437 | -2,533 |
| Net Income | $-27,783 | $-200,736 | $-3,133 | $-3,437 | $-2,533 |
| EPS Basic Total Ops | -0.62 | 2.90 | -2.36 | -2.60 | -1.92 |
| EPS Basic Continuous Ops | -0.81 | -147.08 | -2.36 | -2.60 | -1.92 |
| EPS Diluted Total Ops | -0.62 | 2.90 | -2.36 | -2.60 | -1.92 |
| EPS Diluted Continuous Ops | -0.81 | -147.08 | -2.36 | -2.60 | -1.92 |
| EPS Diluted Before Non-Recurring Items | -0.62 | N/A | -2.36 | -2.60 | -1.92 |
| EBITDA(a) | $-30,806 | $-201,690 | $-3,151 | $-3,415 | $-2,594 |